SAN MATEO, Calif., Oct. 8, 2024 /PRNewswire/ — Selonterra, Inc. (www.selonterra.com), a biotechnology company developing transformative therapies for neurodegenerative disorders announces a second grant award of US$2,500,000 from The Michael J. Fox Foundation for Parkinson’s Research…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.